ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP2877	Vitamin D receptor pathway	18/184	143/6030	2.6188382023508e-07	6.75660256206506e-05	6.72627917235363e-05	604/820/634/78989/1543/1591/168002/1946/727936/9173/27035/6279/6280/219855/25928/79689/8600/54210	18
WP2848	Pluripotent stem cell differentiation pathway	6/184	34/6030	0.000490755518124025	0.0633074618379993	0.0630233402222432	3577/22943/2246/10637/7018/8600	6
WP1423	Ganglio sphingolipid metabolism	3/184	10/6030	0.00286304208096187	0.246221618962721	0.245116585177086	8708/30815/6489	3
WP3527	Pre-implantation embryo	5/184	35/6030	0.0038652793909936	0.249310520719087	0.248191624053274	366/1958/2354/4603/7004	5
WP5188	Retinol metabolism	3/184	12/6030	0.00501760861361091	0.258908604462323	0.257746631941276	1543/10170/195814	3
WP24	Peptide GPCRs	5/184	41/6030	0.00770157838339393	0.331167870485939	0.329681600973354	3577/2358/4886/4887/5540	5
WP455	GPCRs, class A rhodopsin-like	9/184	118/6030	0.00966612169812624	0.356265628302367	0.354666720953805	1238/136/3577/2358/2852/3357/4886/4887/5540	9
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	6/184	65/6030	0.0138292268684693	0.445992566508135	0.443990967882436	22943/2354/8456/25928/11005/7704	6
WP5094	Orexin receptor pathway	8/184	112/6030	0.0206390706038078	0.591653357309156	0.588998038284105	655/1958/2354/2904/4314/6506/6513/114088	8
WP5083	Neuroinflammation and glutamatergic signaling	8/184	115/6030	0.0237818760188912	0.592821575172362	0.590161013227484	816/1610/2904/2918/7850/6506/6513/92745	8
WP1533	Vitamin B12 metabolism	4/184	37/6030	0.025275338476341	0.592821575172362	0.590161013227484	3043/6288/6289/6947	4
WP4917	Proximal tubule transport	4/184	42/6030	0.0381172744924018	0.819521401586639	0.815843418960179	760/762/6513/160728	4
WP3930	EDA signaling in hair follicle development	2/184	11/6030	0.0424996847497574	0.830282503153192	0.826556225089265	22943/25928	2
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/184	65/6030	0.047447243968632	0.830282503153192	0.826556225089265	816/22943/84623/4868/5329	5
WP4698	Vitamin D-sensitive calcium signaling in depression	3/184	29/6030	0.057138779070914	0.830282503153192	0.826556225089265	793/2904/3786	3
WP3958	GPR40 pathway	2/184	13/6030	0.0579266862665018	0.830282503153192	0.826556225089265	5333/113026	2
WP4723	Omega-3 / omega-6 fatty acid synthesis	2/184	13/6030	0.0579266862665018	0.830282503153192	0.826556225089265	9415/5322	2
WP4724	Omega-9 fatty acid synthesis	2/184	13/6030	0.0579266862665018	0.830282503153192	0.826556225089265	79071/9415	2
WP5115	Network map of SARS-CoV-2 signaling pathway	10/184	190/6030	0.0645109263525413	0.854731852923549	0.850895847055675	9332/3577/1958/3043/10410/7850/6288/6289/5104/7018	10
WP3971	OSX and miRNAs in tooth development	2/184	14/6030	0.0662582831723681	0.854731852923549	0.850895847055675	655/22943	2
WP3624	Lung fibrosis	4/184	52/6030	0.0731542816549116	0.886840178227065	0.882860071348037	655/2246/727897/729238	4
WP5053	Development of ureteric collection system	4/184	53/6030	0.0773287839062056	0.886840178227065	0.882860071348037	655/168667/9620/3237	4
WP247	Small ligand GPCRs	2/184	16/6030	0.0839998023536812	0.886840178227065	0.882860071348037	9294/1903	2
WP117	GPCRs, other	3/184	37/6030	0.102104875204996	0.886840178227065	0.882860071348037	9620/3577/2918	3
WP5149	Lipid metabolism in senescent cells	2/184	18/6030	0.102986209698727	0.886840178227065	0.882860071348037	8399/5322	2
WP43	Oxidation by cytochrome P450	3/184	38/6030	0.108491372796953	0.886840178227065	0.882860071348037	1543/1591/339761	3
WP383	Striated muscle contraction pathway	2/184	21/6030	0.133342235084791	0.886840178227065	0.882860071348037	7134/7273	2
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	4/184	68/6030	0.152913532766215	0.886840178227065	0.882860071348037	816/820/1591/5333	4
WP2865	IL1 and megakaryocytes in obesity	2/184	23/6030	0.15455881156096	0.886840178227065	0.882860071348037	6280/8991	2
WP3658	Wnt/beta-catenin signaling pathway in leukemia	2/184	23/6030	0.15455881156096	0.886840178227065	0.882860071348037	22943/7704	2
WP129	Matrix metalloproteinases	2/184	24/6030	0.165398012171282	0.886840178227065	0.882860071348037	4326/4314	2
WP26	S1P receptor signal transduction	2/184	24/6030	0.165398012171282	0.886840178227065	0.882860071348037	9294/1903	2
WP5205	Clock-controlled autophagy in bone metabolism	4/184	71/6030	0.170552781844982	0.886840178227065	0.882860071348037	79365/22943/5187/8600	4
WP4900	Purinergic signaling	2/184	25/6030	0.176365740852082	0.886840178227065	0.882860071348037	136/286530	2
WP176	Folate metabolism	3/184	48/6030	0.179674287672481	0.886840178227065	0.882860071348037	3043/6288/6289	3
WP558	Complement and coagulation cascades	3/184	48/6030	0.179674287672481	0.886840178227065	0.882860071348037	1191/5329/5104	3
WP241	One-carbon metabolism	2/184	26/6030	0.187444197018523	0.886840178227065	0.882860071348037	23382/10840	2
WP299	Nuclear receptors in lipid metabolism and toxicity	2/184	26/6030	0.187444197018523	0.886840178227065	0.882860071348037	8647/1591	2
WP4875	Disruption of postsynaptic signaling by CNV	2/184	26/6030	0.187444197018523	0.886840178227065	0.882860071348037	816/2904	2
WP2882	Nuclear receptors meta-pathway	11/184	268/6030	0.194759758497866	0.886840178227065	0.882860071348037	8647/1543/1958/9982/55554/81706/9588/6286/6513/160728/11254	11
WP2806	Complement system	4/184	75/6030	0.195107619092109	0.886840178227065	0.882860071348037	2214/5329/729238/11326	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	6/184	128/6030	0.195845043301222	0.886840178227065	0.882860071348037	1958/9734/3359/5452/7018/11076	6
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	2/184	27/6030	0.198616535904776	0.886840178227065	0.882860071348037	4314/27035	2
WP4481	Resistin as a regulator of inflammation	2/184	28/6030	0.209866827334289	0.886840178227065	0.882860071348037	5333/113026	2
WP408	Oxidative stress response	2/184	29/6030	0.221180016094539	0.886840178227065	0.882860071348037	1543/27035	2
WP2406	Cardiac progenitor differentiation	2/184	31/6030	0.243939012589454	0.886840178227065	0.882860071348037	22943/55897	2
WP4018	Clear cell renal cell carcinoma pathways	4/184	83/6030	0.247083050438971	0.886840178227065	0.882860071348037	79365/3099/197257/6513	4
WP3298	Melatonin metabolism and effects	2/184	32/6030	0.255358749394702	0.886840178227065	0.882860071348037	1543/5187	2
WP4823	Genes controlling nephrogenesis	2/184	32/6030	0.255358749394702	0.886840178227065	0.882860071348037	3237/4868	2
WP2007	Iron metabolism in placenta	1/184	10/6030	0.266647341245997	0.886840178227065	0.882860071348037	7018	1
WP4259	Disorders of folate metabolism and transport	1/184	10/6030	0.266647341245997	0.886840178227065	0.882860071348037	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/184	10/6030	0.266647341245997	0.886840178227065	0.882860071348037	8647	1
WP15	Selenium micronutrient network	3/184	59/6030	0.268298695176004	0.886840178227065	0.882860071348037	3043/6288/6289	3
WP4008	NO/cGMP/PKG mediated neuroprotection	2/184	34/6030	0.278219060019613	0.886840178227065	0.882860071348037	816/2904	2
WP2884	NRF2 pathway	5/184	116/6030	0.279750419289632	0.886840178227065	0.882860071348037	1958/9588/6513/160728/11254	5
WP4271	Vitamin B12 disorders	1/184	11/6030	0.289062106895621	0.886840178227065	0.882860071348037	6947	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/184	11/6030	0.289062106895621	0.886840178227065	0.882860071348037	604	1
WP4629	Aerobic glycolysis	1/184	11/6030	0.289062106895621	0.886840178227065	0.882860071348037	6513	1
WP4788	Autosomal recessive osteopetrosis pathways	1/184	11/6030	0.289062106895621	0.886840178227065	0.882860071348037	8600	1
WP5052	Nephrogenesis	1/184	11/6030	0.289062106895621	0.886840178227065	0.882860071348037	655	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/184	11/6030	0.289062106895621	0.886840178227065	0.882860071348037	2358	1
WP5130	Th17 cell differentiation pathway	3/184	62/6030	0.293408749061815	0.886840178227065	0.882860071348037	50615/9572/5187	3
WP2447	Amyotrophic lateral sclerosis (ALS)	2/184	36/6030	0.30103564479229	0.886840178227065	0.882860071348037	4741/6506	2
WP4754	IL-18 signaling pathway	9/184	239/6030	0.306230952105958	0.886840178227065	0.882860071348037	2904/8870/81618/10365/4314/27035/7018/7052/8600	9
WP2857	Mesodermal commitment pathway	5/184	121/6030	0.309651284409208	0.886840178227065	0.882860071348037	655/1466/22943/8325/10637	5
WP2023	Cell differentiation - expanded index	1/184	12/6030	0.310795380251861	0.886840178227065	0.882860071348037	10637	1
WP2881	Estrogen receptor pathway	1/184	12/6030	0.310795380251861	0.886840178227065	0.882860071348037	1543	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/184	12/6030	0.310795380251861	0.886840178227065	0.882860071348037	22943	1
WP4211	Transcriptional cascade regulating adipogenesis	1/184	12/6030	0.310795380251861	0.886840178227065	0.882860071348037	10365	1
WP5110	Familial hyperlipidemia type 3	1/184	12/6030	0.310795380251861	0.886840178227065	0.882860071348037	7436	1
WP5173	Disorders of galactose metabolism 	1/184	12/6030	0.310795380251861	0.886840178227065	0.882860071348037	5836	1
WP4148	Splicing factor NOVA regulated synaptic proteins	2/184	37/6030	0.312403117340135	0.886840178227065	0.882860071348037	1946/2904	2
WP2880	Glucocorticoid receptor pathway	3/184	65/6030	0.318670144690138	0.886840178227065	0.882860071348037	9982/81706/6286	3
WP5218	Extrafollicular B cell activation by SARS-CoV-2	3/184	65/6030	0.318670144690138	0.886840178227065	0.882860071348037	57379/60468/604	3
WP185	Integrin-mediated cell adhesion	4/184	94/6030	0.322523895448401	0.886840178227065	0.882860071348037	11131/827/3681/84665	4
WP500	Glycogen synthesis and degradation	2/184	38/6030	0.323731547592534	0.886840178227065	0.882860071348037	3099/5836	2
WP2289	Drug induction of bile acid pathway	1/184	13/6030	0.331867771417307	0.886840178227065	0.882860071348037	8647	1
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1/184	13/6030	0.331867771417307	0.886840178227065	0.882860071348037	7134	1
WP5176	Disorders of bile acid synthesis and biliary transport	1/184	13/6030	0.331867771417307	0.886840178227065	0.882860071348037	8647	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/184	13/6030	0.331867771417307	0.886840178227065	0.882860071348037	1903	1
WP536	Calcium regulation in cardiac cells	5/184	125/6030	0.33389243989848	0.886840178227065	0.882860071348037	782/816/2707/5569/8787	5
WP3937	Microglia pathogen phagocytosis pathway	2/184	39/6030	0.335012764129559	0.886840178227065	0.882860071348037	54210/54209	2
WP5097	CCL18 signaling pathway	2/184	39/6030	0.335012764129559	0.886840178227065	0.882860071348037	6513/7004	2
WP534	Glycolysis and gluconeogenesis	2/184	39/6030	0.335012764129559	0.886840178227065	0.882860071348037	3099/6513	2
WP4222	Phosphodiesterases in neuronal function	2/184	40/6030	0.346239125108218	0.886840178227065	0.882860071348037	2904/5145	2
WP4312	Rett syndrome causing genes	2/184	40/6030	0.346239125108218	0.886840178227065	0.882860071348037	2904/6334	2
WP12	Osteoclast signaling	1/184	14/6030	0.352299270513072	0.886840178227065	0.882860071348037	8600	1
WP2879	Farnesoid X receptor pathway	1/184	14/6030	0.352299270513072	0.886840178227065	0.882860071348037	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/184	14/6030	0.352299270513072	0.886840178227065	0.882860071348037	1466	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/184	14/6030	0.352299270513072	0.886840178227065	0.882860071348037	1152	1
WP58	Monoamine GPCRs	1/184	14/6030	0.352299270513072	0.886840178227065	0.882860071348037	3357	1
WP697	Estrogen metabolism	1/184	14/6030	0.352299270513072	0.886840178227065	0.882860071348037	1543	1
WP3594	Circadian rhythm genes	6/184	159/6030	0.357186798119144	0.886840178227065	0.882860071348037	79365/1958/4887/9572/5187/60675	6
WP5220	Metabolic reprogramming in pancreatic cancer	2/184	41/6030	0.357403493853401	0.886840178227065	0.882860071348037	3099/6513	2
WP4673	Male infertility	4/184	100/6030	0.364481508603944	0.886840178227065	0.882860071348037	1191/1543/8787/128153	4
WP1946	Cori cycle	1/184	15/6030	0.372109266228763	0.886840178227065	0.882860071348037	6513	1
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	1/184	15/6030	0.372109266228763	0.886840178227065	0.882860071348037	255738	1
WP5109	Familial hyperlipidemia type 2	1/184	15/6030	0.372109266228763	0.886840178227065	0.882860071348037	255738	1
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	2/184	43/6030	0.379520094175331	0.886840178227065	0.882860071348037	816/2904	2
WP5095	Overview of proinflammatory and profibrotic mediators	3/184	73/6030	0.385913302554299	0.886840178227065	0.882860071348037	6369/29949/4314	3
WP410	Exercise-induced circadian regulation	2/184	44/6030	0.390460372108665	0.886840178227065	0.882860071348037	5187/10381	2
WP4971	Phosphoinositides metabolism	2/184	44/6030	0.390460372108665	0.886840178227065	0.882860071348037	5333/113026	2
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	1/184	16/6030	0.391316563820435	0.886840178227065	0.882860071348037	8325	1
WP4478	LTF danger signal response pathway	1/184	16/6030	0.391316563820435	0.886840178227065	0.882860071348037	54210	1
WP4538	Regulatory circuits of the STAT3 signaling pathway	3/184	75/6030	0.402536376714459	0.886840178227065	0.882860071348037	1844/53832/50615	3
WP3287	Overview of nanoparticle effects	1/184	17/6030	0.409939402572852	0.886840178227065	0.882860071348037	3681	1
WP3967	miR-509-3p alteration of YAP1/ECM axis	1/184	17/6030	0.409939402572852	0.886840178227065	0.882860071348037	7004	1
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	1/184	17/6030	0.409939402572852	0.886840178227065	0.882860071348037	1591	1
WP5074	Kallmann syndrome	1/184	17/6030	0.409939402572852	0.886840178227065	0.882860071348037	60675	1
WP691	Tamoxifen metabolism	1/184	17/6030	0.409939402572852	0.886840178227065	0.882860071348037	1543	1
WP2849	Hematopoietic stem cell differentiation	2/184	46/6030	0.412078158827909	0.886840178227065	0.882860071348037	2354/23650	2
WP4533	Transcription co-factors SKI and SKIL protein partners	1/184	18/6030	0.427995472741918	0.886840178227065	0.882860071348037	7004	1
WP497	Urea cycle and metabolism of amino groups	1/184	18/6030	0.427995472741918	0.886840178227065	0.882860071348037	1152	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/184	18/6030	0.427995472741918	0.886840178227065	0.882860071348037	1958	1
WP3646	Hepatitis C and hepatocellular carcinoma	2/184	48/6030	0.433314500308504	0.886840178227065	0.882860071348037	3577/7345	2
WP2895	Differentiation of white and brown adipocyte	1/184	19/6030	0.445501931992665	0.886840178227065	0.882860071348037	655	1
WP325	Triacylglyceride synthesis	1/184	19/6030	0.445501931992665	0.886840178227065	0.882860071348037	56895	1
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/184	19/6030	0.445501931992665	0.886840178227065	0.882860071348037	8708	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/184	19/6030	0.445501931992665	0.886840178227065	0.882860071348037	6513	1
WP4722	Glycerolipids and glycerophospholipids	1/184	19/6030	0.445501931992665	0.886840178227065	0.882860071348037	56895	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/184	19/6030	0.445501931992665	0.886840178227065	0.882860071348037	3357	1
WP560	TGF-beta receptor signaling	2/184	50/6030	0.454137085213914	0.886840178227065	0.882860071348037	25805/10637	2
WP167	Eicosanoid synthesis	1/184	20/6030	0.462475421347739	0.886840178227065	0.882860071348037	5322	1
WP2878	PPAR-alpha pathway	1/184	20/6030	0.462475421347739	0.886840178227065	0.882860071348037	55554	1
WP5044	Kynurenine pathway and links to cell senescence	1/184	20/6030	0.462475421347739	0.886840178227065	0.882860071348037	7850	1
WP673	ErbB signaling pathway	3/184	83/6030	0.467541185688271	0.886840178227065	0.882860071348037	816/2069/145957	3
WP1772	Apoptosis modulation and signaling	3/184	84/6030	0.475457792305037	0.886840178227065	0.882860071348037	638/8739/7850	3
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	1/184	21/6030	0.478932080660886	0.886840178227065	0.882860071348037	1591	1
WP3942	PPAR signaling pathway	2/184	54/6030	0.494437310833003	0.886840178227065	0.882860071348037	9415/28965	2
WP4816	TGF-beta receptor signaling in skeletal dysplasias	2/184	54/6030	0.494437310833003	0.886840178227065	0.882860071348037	25805/10637	2
WP3591	Sleep regulation	1/184	22/6030	0.4948875636295	0.886840178227065	0.882860071348037	4887	1
WP4537	Hippo-Yap signaling pathway	1/184	22/6030	0.4948875636295	0.886840178227065	0.882860071348037	7004	1
WP712	Estrogen signaling pathway	1/184	22/6030	0.4948875636295	0.886840178227065	0.882860071348037	2852	1
WP2858	Ectoderm differentiation	4/184	120/6030	0.501333188871498	0.886840178227065	0.882860071348037	1496/8325/5452/7704	4
WP2361	Gastric cancer network 1	1/184	23/6030	0.510357052359888	0.886840178227065	0.882860071348037	6286	1
WP34	Ovarian infertility	1/184	23/6030	0.510357052359888	0.886840178227065	0.882860071348037	1958	1
WP3893	Development and heterogeneity of the ILC family	1/184	23/6030	0.510357052359888	0.886840178227065	0.882860071348037	7704	1
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	1/184	23/6030	0.510357052359888	0.886840178227065	0.882860071348037	6513	1
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	1/184	23/6030	0.510357052359888	0.886840178227065	0.882860071348037	27035	1
WP3584	MECP2 and associated Rett syndrome	2/184	56/6030	0.513874428066014	0.886840178227065	0.882860071348037	604/54715	2
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	1/184	24/6030	0.525355271498523	0.886840178227065	0.882860071348037	2358	1
WP3931	Embryonic stem cell pluripotency pathways	3/184	91/6030	0.529267760633904	0.886840178227065	0.882860071348037	2246/2256/8325	3
WP3680	Physico-chemical features and toxicity-associated pathways	2/184	58/6030	0.532815853809733	0.886840178227065	0.882860071348037	8325/4741	2
WP702	Metapathway biotransformation Phase I and II	4/184	125/6030	0.533707007577006	0.886840178227065	0.882860071348037	1543/1591/339761/64090	4
WP231	TNF-alpha signaling pathway	3/184	92/6030	0.536705860620808	0.886840178227065	0.882860071348037	27035/124056/5836	3
WP3613	Photodynamic therapy-induced unfolded protein response	1/184	25/6030	0.539896501942125	0.886840178227065	0.882860071348037	121506	1
WP4969	RAS and bradykinin pathways in COVID-19	1/184	25/6030	0.539896501942125	0.886840178227065	0.882860071348037	1591	1
WP5092	Interactions of natural killer cells in pancreatic cancer	1/184	25/6030	0.539896501942125	0.886840178227065	0.882860071348037	2214	1
WP183	Proteasome degradation	2/184	59/6030	0.542097157621443	0.886840178227065	0.882860071348037	3135/7345	2
WP5090	Complement system in neuronal development and plasticity	3/184	93/6030	0.544077487860552	0.886840178227065	0.882860071348037	1191/78989/286204	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	2/184	60/6030	0.551250706089017	0.886840178227065	0.882860071348037	782/1496	2
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/184	26/6030	0.553994594139068	0.886840178227065	0.882860071348037	8600	1
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	1/184	26/6030	0.553994594139068	0.886840178227065	0.882860071348037	5322	1
WP4155	Endometrial cancer	2/184	61/6030	0.560275616834323	0.886840178227065	0.882860071348037	1496/2246	2
WP4313	Ferroptosis	2/184	61/6030	0.560275616834323	0.886840178227065	0.882860071348037	27035/7018	2
WP2197	Endothelin pathways	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	4886	1
WP2525	Trans-sulfuration and one-carbon metabolism	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	23382	1
WP3869	Cannabinoid receptor signaling	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	1543	1
WP3996	Ethanol effects on histone modifications	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	9734	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	27035	1
WP5102	Familial partial lipodystrophy (FPLD)	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	10365	1
WP5121	Sphingolipid metabolism in senescence	1/184	27/6030	0.567662980994234	0.886840178227065	0.882860071348037	9294	1
WP289	Myometrial relaxation and contraction pathways	4/184	131/6030	0.571146660477128	0.886840178227065	0.882860071348037	816/5569/5333/8787	4
WP5055	Burn wound healing	3/184	97/6030	0.572876672822768	0.886840178227065	0.882860071348037	4314/6280/8796	3
WP428	Wnt signaling	3/184	98/6030	0.579899674646595	0.886840178227065	0.882860071348037	816/22943/8325	3
WP4150	Wnt signaling in kidney disease	1/184	28/6030	0.580914690389047	0.886840178227065	0.882860071348037	8325	1
WP4561	Cell migration and invasion through p75NTR	1/184	28/6030	0.580914690389047	0.886840178227065	0.882860071348037	1946	1
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	1/184	28/6030	0.580914690389047	0.886840178227065	0.882860071348037	8600	1
WP4838	Regucalcin in proximal tubule epithelial kidney cells	1/184	28/6030	0.580914690389047	0.886840178227065	0.882860071348037	8600	1
WP2374	Oncostatin M signaling pathway	2/184	64/6030	0.586572216315031	0.88901902520037	0.885029139734354	1958/4314	2
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	4/184	134/6030	0.589233539958385	0.88901902520037	0.885029139734354	1958/2904/84894/10603	4
WP4549	Fragile X syndrome	3/184	101/6030	0.600531156083744	0.898013623061372	0.893983370163095	816/54869/2904	3
WP2839	Hair follicle development: organogenesis - part 2 of 3	1/184	30/6030	0.606218235723674	0.898013623061372	0.893983370163095	2246	1
WP4149	White fat cell differentiation	1/184	30/6030	0.606218235723674	0.898013623061372	0.893983370163095	10365	1
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/184	31/6030	0.618294209828148	0.898013623061372	0.893983370163095	9734	1
WP4241	Type 2 papillary renal cell carcinoma	1/184	31/6030	0.618294209828148	0.898013623061372	0.893983370163095	6513	1
WP2064	Neural crest differentiation	2/184	68/6030	0.619807735404633	0.898013623061372	0.893983370163095	655/9734	2
WP382	MAPK signaling pathway	6/184	210/6030	0.624365994618741	0.898013623061372	0.893983370163095	782/1844/2246/2256/7850/25780	6
WP3995	Prion disease pathway	1/184	32/6030	0.630001805326001	0.898013623061372	0.893983370163095	5452	1
WP3998	Prader-Willi and Angelman syndrome	1/184	32/6030	0.630001805326001	0.898013623061372	0.893983370163095	4948	1
WP4542	Leukocyte-intrinsic Hippo pathway functions	1/184	32/6030	0.630001805326001	0.898013623061372	0.893983370163095	7004	1
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1/184	33/6030	0.64135220009426	0.899287324045212	0.895251354822651	4314	1
WP465	Tryptophan metabolism	1/184	33/6030	0.64135220009426	0.899287324045212	0.895251354822651	1543	1
WP4756	Renin-angiotensin-aldosterone system (RAAS)	1/184	33/6030	0.64135220009426	0.899287324045212	0.895251354822651	816	1
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	2/184	72/6030	0.650961060857292	0.900042291645079	0.896002934155036	22943/8325	2
WP619	Type II interferon signaling	1/184	34/6030	0.652356234641976	0.900042291645079	0.896002934155036	2633	1
WP716	Vitamin A and carotenoid metabolism	1/184	34/6030	0.652356234641976	0.900042291645079	0.896002934155036	195814	1
WP2371	Parkinson's disease pathway	1/184	35/6030	0.66302442223802	0.900148576963777	0.89610874246904	7345	1
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1/184	35/6030	0.66302442223802	0.900148576963777	0.89610874246904	6513	1
WP5198	Inflammatory bowel disease signaling	1/184	35/6030	0.66302442223802	0.900148576963777	0.89610874246904	50615	1
WP2873	Aryl hydrocarbon receptor pathway	1/184	36/6030	0.673366958736469	0.900148576963777	0.89610874246904	1543	1
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1/184	36/6030	0.673366958736469	0.900148576963777	0.89610874246904	84676	1
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	1/184	36/6030	0.673366958736469	0.900148576963777	0.89610874246904	10410	1
WP4331	Neovascularisation processes	1/184	37/6030	0.68339373210859	0.908843210742351	0.904764355043385	94	1
WP4758	Nephrotic syndrome	1/184	38/6030	0.693114331690105	0.909483305587586	0.905401577165937	4868	1
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	2/184	78/6030	0.69386096992778	0.909483305587586	0.905401577165937	22943/8325	2
WP5124	Alzheimer's disease	6/184	226/6030	0.694450431010676	0.909483305587586	0.905401577165937	22943/8325/2904/3800/27035/10381	6
WP2853	Endoderm differentiation	3/184	118/6030	0.704533729777755	0.916077549880721	0.911966226727442	655/22943/1844	3
WP2059	Alzheimer's disease and miRNA effects	6/184	229/6030	0.706586947388618	0.916077549880721	0.911966226727442	22943/8325/2904/3800/27035/10381	6
WP4963	p53 transcriptional gene network	2/184	81/6030	0.713637911589221	0.920294467899628	0.916164219369683	136/6513	2
WP4290	Metabolic reprogramming in colon cancer	1/184	41/6030	0.720530688038415	0.920294467899628	0.916164219369683	6513	1
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	1/184	42/6030	0.729116821516614	0.920294467899628	0.916164219369683	84676	1
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	1/184	42/6030	0.729116821516614	0.920294467899628	0.916164219369683	7004	1
WP4223	Ras signaling	4/184	161/6030	0.730553239474495	0.920294467899628	0.916164219369683	2904/8399/5322/25780	4
WP5087	Malignant pleural mesothelioma	10/184	381/6030	0.735471784608577	0.920294467899628	0.916164219369683	1496/22943/1825/1946/2246/2256/8325/4314/6513/7004	10
WP2586	Aryl hydrocarbon receptor pathway	1/184	43/6030	0.737440553119978	0.920294467899628	0.916164219369683	1543	1
WP2038	Microtubule cytoskeleton regulation	1/184	44/6030	0.745509859655125	0.920294467899628	0.916164219369683	11076	1
WP2267	Synaptic vesicle pathway	1/184	44/6030	0.745509859655125	0.920294467899628	0.916164219369683	23025	1
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/184	44/6030	0.745509859655125	0.920294467899628	0.916164219369683	81706	1
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	1/184	45/6030	0.753332476732214	0.925522757128149	0.921369044223861	9415	1
WP4262	Breast cancer pathway	3/184	129/6030	0.760080366235176	0.929387367244907	0.925216310109169	2246/8325/8600	3
WP2272	Pathogenic Escherichia coli infection	1/184	49/6030	0.782302720988492	0.945768686332854	0.9415241104252	10381	1
WP4239	Epithelial to mesenchymal transition in colorectal cancer	3/184	134/6030	0.782408792540158	0.945768686332854	0.9415241104252	8999/9073/8325	3
WP3286	Copper homeostasis	1/184	51/6030	0.795492287204168	0.945768686332854	0.9415241104252	79689	1
WP23	B cell receptor signaling pathway	2/184	96/6030	0.797098358161648	0.945768686332854	0.9415241104252	604/25780	2
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1/184	52/6030	0.801785884654316	0.945768686332854	0.9415241104252	8870	1
WP4906	3q29 copy number variation syndrome	1/184	52/6030	0.801785884654316	0.945768686332854	0.9415241104252	7018	1
WP2431	Spinal cord injury	2/184	98/6030	0.806442130112775	0.945768686332854	0.9415241104252	1958/5322	2
WP4787	Osteoblast differentiation and related diseases	2/184	98/6030	0.806442130112775	0.945768686332854	0.9415241104252	2246/8325	2
WP2795	Cardiac hypertrophic response	1/184	53/6030	0.80788682095803	0.945768686332854	0.9415241104252	9734	1
WP3888	VEGFA-VEGFR2 signaling pathway	10/184	409/6030	0.810524435947179	0.945768686332854	0.9415241104252	1466/22943/1958/10755/9734/3748/5322/5329/9588/7004	10
WP2018	RANKL/RANK signaling pathway	1/184	54/6030	0.813800962658502	0.945768686332854	0.9415241104252	8600	1
WP4541	Hippo-Merlin signaling dysregulation	2/184	101/6030	0.819744163538297	0.94806854992192	0.943813652309052	3681/7004	2
WP710	DNA damage response (only ATM dependent)	2/184	103/6030	0.828153831919531	0.94806854992192	0.943813652309052	604/638	2
WP474	Endochondral ossification	1/184	57/6030	0.830478652257186	0.94806854992192	0.943813652309052	655	1
WP4808	Endochondral ossification with skeletal dysplasias	1/184	57/6030	0.830478652257186	0.94806854992192	0.943813652309052	655	1
WP3651	Pathways affected in adenoid cystic carcinoma	1/184	58/6030	0.835700806615913	0.949827348488571	0.945564557450883	4603	1
WP304	Kit receptor signaling pathway	1/184	59/6030	0.840762938495128	0.951389640928697	0.94711983837863	10603	1
WP4659	Gastrin signaling pathway	2/184	108/6030	0.847660005527443	0.955005595747076	0.95071956492161	1958/3067	2
WP2359	Parkin-ubiquitin proteasomal system pathway	1/184	62/6030	0.85503724021726	0.959128730330666	0.954824195025224	10381	1
WP481	Insulin signaling	3/184	156/6030	0.86121261050187	0.960648424413714	0.95633706877579	1958/10603/6513	3
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	1/184	64/6030	0.863838893271247	0.960648424413714	0.95633706877579	1958	1
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/184	66/6030	0.872108867714766	0.965682780559697	0.961348830912143	820	1
WP4949	16p11.2 proximal deletion syndrome	1/184	67/6030	0.876054536450595	0.965906283778861	0.961571331056883	23025	1
WP4656	Joubert syndrome	1/184	71/6030	0.890662722054807	0.970216112303531	0.965861817225873	5145	1
WP4217	Ebola virus infection in host	2/184	124/6030	0.897333162662779	0.970216112303531	0.965861817225873	26762/3135	2
WP51	Regulation of actin cytoskeleton	2/184	127/6030	0.904788556933301	0.970216112303531	0.965861817225873	2246/2256	2
WP2328	Allograft rejection	1/184	76/6030	0.906537360783528	0.970216112303531	0.965861817225873	3135	1
WP4016	DNA IR-damage and cellular response via ATR	1/184	76/6030	0.906537360783528	0.970216112303531	0.965861817225873	604	1
WP3925	Amino acid metabolism	1/184	77/6030	0.909425692260826	0.970216112303531	0.965861817225873	3067	1
WP2355	Corticotropin-releasing hormone signaling pathway	1/184	78/6030	0.912225234109307	0.970216112303531	0.965861817225873	2354	1
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	5/184	265/6030	0.91351191683395	0.970216112303531	0.965861817225873	1946/2246/2256/3681/6513	5
WP4022	Pyrimidine metabolism	1/184	79/6030	0.914938701334422	0.970216112303531	0.965861817225873	956	1
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1/184	80/6030	0.91756872636458	0.970216112303531	0.965861817225873	9734	1
WP254	Apoptosis	1/184	84/6030	0.927304300715744	0.971502561090792	0.967142492477166	8739	1
WP4540	Hippo signaling regulation pathways	1/184	84/6030	0.927304300715744	0.971502561090792	0.967142492477166	7004	1
WP69	T-cell receptor signaling pathway	1/184	86/6030	0.931734215745229	0.971502561090792	0.967142492477166	3604	1
WP399	Wnt signaling pathway and pluripotency	1/184	87/6030	0.933847423064017	0.971502561090792	0.967142492477166	8325	1
WP4657	22q11.2 copy number variation syndrome	1/184	90/6030	0.939804530659369	0.973773369116936	0.969403109198419	150209	1
WP4658	Small cell lung cancer	1/184	93/6030	0.945227847050692	0.975475138156314	0.971097240759448	22798	1
WP5224	2q37 copy number variation syndrome	1/184	104/6030	0.961271421554873	0.988079787893057	0.983645321280726	64090	1
WP4172	PI3K-Akt signaling pathway	4/184	280/6030	0.974978444553287	0.99663927881785	0.992166397517566	1946/2246/2256/22798	4
WP3915	Angiopoietin-like protein 8 regulatory pathway	1/184	125/6030	0.980053367371848	0.99663927881785	0.992166397517566	6513	1
WP366	TGF-beta signaling pathway	1/184	130/6030	0.982974253940047	0.99663927881785	0.992166397517566	2354	1
WP4396	Nonalcoholic fatty liver disease	1/184	137/6030	0.986362404208911	0.99663927881785	0.992166397517566	125965	1
WP3929	Chemokine signaling pathway	1/184	152/6030	0.991530807053072	0.99663927881785	0.992166397517566	6369	1
WP437	EGF/EGFR signaling pathway	1/184	157/6030	0.992776335876695	0.99663927881785	0.992166397517566	2354	1
WP4352	Ciliary landscape	1/184	201/6030	0.998228975250461	0.998228975250461	0.993748959449663	4741	1
